Projects per year
Fingerprint
Dive into the research topics where Mark Rubinstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities
Rubinstein, M. (PI) & Camp, E. R. (CoPI)
08/1/23 → 07/31/25
Project: Research
-
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses
Wrangle, J. (PI) & Rubinstein, M. (CoPI)
04/1/19 → 03/31/24
Project: Research
-
Maximizing Memory T Cell Responses by Matured Post Chemotherapy Dendritic Cells
Rubinstein, M. (PI)
03/1/10 → 02/28/13
Project: Research
-
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19
Adhikari, B., Bednash, J. S., Horowitz, J. C., Rubinstein, M. P. & Vlasova, A. N., Feb 6 2024, In: Frontiers in immunology. 15, p. 1325243 1325243.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Corrigendum: Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19 (Frontiers in Immunology, (2024), 15, (1325243), 10.3389/fimmu.2024.1325243)
Adhikari, B., Bednash, J. S., Horowitz, J. C., Rubinstein, M. P. & Vlasova, A. N., 2024, In: Frontiers in immunology. 15, 1384209.Research output: Contribution to journal › Comment/debate
Open Access -
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer
Song, N. J., Chakravarthy, K. B., Jeon, H., Bolyard, C., Reynolds, K., Weller, K. P., Reisinger, S., Wang, Y., Li, A., Jiang, S., Ma, Q., Barouch, D. H., Rubinstein, M. P., Shields, P. G., Oltz, E. M., Chung, D. & Li, Z., Jan 4 2024, In: Journal for ImmunoTherapy of Cancer. 12, 1, e007922.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma
Denlinger, N., Song, N. J., Zhang, X., Jeon, H., Peterson, C., Wang, Y., Reynolds, K., Bolz, R. M., Miao, J., Song, C., Wu, D., Chan, W. K., Bezerra, E., Epperla, N., Voorhees, T. J., Brammer, J., Kittai, A. S., Bond, D. A., Sawalha, Y. & Sigmund, A. & 14 others, , Jun 25 2024, In: Blood Advances. 8, 12, p. 3140-3153 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy
Zhou, L., Velegraki, M., Wang, Y., Mandula, J. K., Chang, Y., Liu, W., Song, N. J., Kwon, H., Xiao, T., Bolyard, C., Hong, F., Xin, G., Ma, Q., Rubinstein, M. P., Wen, H. & Li, Z., Jul 15 2024, In: Journal of Clinical Investigation. 134, 14, e180080.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations